This week on AI in Industry, we speak with Amir Saffari, Senior Vice President of AI at BenevolentAI, a London-based pharmaceutical company that uses machine learning to find new uses for existing drugs and new treatments for diseases. In speaking with him, we aim to learn two things: How will machine learning play a role in the phases of drug discovery, from generating hypotheses to clinical trials? In the future, what are the roles of man and machine in drug discovery? What processes will machines automate and potentially do better than humans in this field? We hope the insights in this episode provide business leaders in the pharma industry with an understanding of the current state of AI in their space and where it might play a role in their industry in the next two to three years. See the full interview article here: www.techemergence.com/future-drug-discovery-ai-role-man-machine

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related